Code Biotherapeutics
Code Biotherapeutics is a DNA-based Gene Therapy Vector founded in 2020 by Brian J. McVeigh, Lori Getts and Robert Getts.
1
Funding Rounds
$75.0m
Money raised
Overview
Code Biotherapeutics is a DNA-based Gene Therapy Vector founded in 2020 by Brian J. McVeigh, Lori Getts and Robert Getts.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro**** Ge*** | - | - | |
| Br*** J. Mc***** | - | - | - |
| Lo** Ge*** | - | - |
Funding series
Funding Series Analysis
The company Code Biotherapeutics has raised a total of $75m in funding over 1 rounds.
Key Insights:
- Code Biotherapeutics Series A round, June 2022: $75m
Code Biotherapeutics Series A round, June 2022
$75m
Industries
Code Biotherapeutics is active in the following industries:
- Healthcare
- Technology
- Biology
- Biotechnology
- Regenerative medicine
- Biomedical engineering
- Tissue engineering
- Engineering